| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.3 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |